Update from the Editorial office of the European Journal of Pharmaceutics and Biopharmaceutics

Author： Gurny R.   Editor-in-Chief  

Publisher： Elsevier

ISSN： 0939-6411

Source： European Journal of Pharmaceutics and Biopharmaceutics, Vol.54, Iss.3, 2002-11, pp. : 261-261

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Editorial: [Hot Topic: Bio-Pharmaceutics and Materials in Oral Cavity]

By  

Current Pharmaceutical Design, Vol. 18, Iss. 34, 2012-11 ,pp. : 5403-5403

Bentham Science Publishers

Access to resources Recommend Favorite

Editorial (Thematic Issue: Molecular Pharmaceutics and Solid-State Chemistry of Drugs)

By  

Current Pharmaceutical Design, Vol. 22, Iss. 32, 2016-09 ,pp. : 4881-4882

Bentham Science Publishers

Access to resources Recommend Favorite

Update on the Office of Drug Safety at the US FDA

By  

Reactions Weekly, Vol. 1, Iss. 1015, 2004-01 ,pp. : 3-4

Adis International

Access to resources Recommend Favorite

Editorial - The new impact factor (1.84) and other recent developments in the European Journal of Pharmaceutical Sciences

By  

European Journal of Pharmaceutical Sciences, Vol. 18, Iss. 1, 2003-01 ,pp. : 1-1

Elsevier

Access to resources Recommend Favorite

Editorial (Thematic Issue: From Gut Inflammation to Gastrointestinal Disorders Current Update on Pathophysiology, Molecular Mechanism and Pharmacological Treatment Modalities)

By  

Current Pharmaceutical Design, Vol. 20, Iss. 7, 2014-02 ,pp. : 1039-1040

Bentham Science Publishers

Access to resources Recommend Favorite